Researchers solve RSV mystery; Sanofi Pasteur blueprints expansion; alliance wins $4.7M

Vaccine research

Merck KGaA paid Oncothyreon $13 million for the right to manufacture Stimuvax, an experimental lung cancer vaccine. Merck already holds the commercialization rights to the vaccine. Report

The Life Sciences Discovery Fund has awarded nearly $4.7M to the Washington Vaccine Alliance for a program to help research new vaccines for E. coli, herpes and syphilis. Report

Vaccine market

Economic development officials in Lehigh County have been wooing Sanofi Pasteur, which is planning to expand its manufacturing capability in the U.S. Report

A seasonal flu outbreak in England has hit young adults particularly hard. Story

Hester launched a poultry vaccine against Coryza disease in chicken. Report

Suggested Articles

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.